Gaplast’s implant syringe is a ready-to-fill injection device suitable for the placement of rod-shaped, long-acting (retarding) biodegradable implants. After subcutaneous administration, these are intended to gradually release their active ingredient into the tissue and then into the patient’s bloodstream. The implant syringe finds predominant applications in hormone therapies, notably in the fields of prostate and breast cancer treatments, long-term contraception, fertility, and anti-aging.

The implant syringe is offered in two distinct sizes for individualised customer solutions. Our cutting-edge manufacturing and assembly processes for the implant syringe adhere to ISO 14644 Class 8 standards, with assembly in GMP Class D clean room conditions for optimum quality assurance.